Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug693 | CELLECTRA™ 2000 Wiki | 1.00 |
| drug1862 | INO-4700 Wiki | 1.00 |
| drug2916 | Placebo Wiki | 0.04 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013577 | Syndrome NIH | 0.09 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
COVIDTrach aims to assess the outcomes of tracheostomy in mechanically ventilated patients with COVID-19. The use of personal protective equipment and incidence of COVID-19 amongst operators is also recorded.
Description: Clinical outcome in terms of time in days from tracheostomy to successful weaning from mechanical ventilation.
Measure: Time to wean Time: 12 monthsDescription: Clinical outcome in terms of length of time from tracheostomy to tracheostomy decannulation.
Measure: Airway related outcomes Time: 12 monthsDescription: Clinical outcome in terms of tracheostomy related complications in terms of bleeding, displaced tube, blocked tube, other.
Measure: Complications Time: 12 monthsDescription: Clinical outcome in terms of length of stay at intensive care and total length of stay in hospital in days.
Measure: Length of stay Time: 12 monthsDescription: Clinical outcomes in terms of patient mortality during or following tracheostomy, timing and cause of death
Measure: Mortality Time: 12 monthsDescription: Following PPE guidance
Measure: Adherence of tracheostomy procedure to national guidance Time: 12 monthsDescription: Symptomatic or test positive COVID-19 infection in healthcare professionals involved in the tracheostomy procedure.
Measure: Operator wellness Time: 12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports